arrow
T

Takeshi Kondo

aiiku hospital
H指数:36
被引数:5,956

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term outcomes of low-dose dasatinib in older patients with chronic myeloid leukemia in chronic phase: an extended follow-up of the DAVLEC phase 2 trial

慢性粒细胞白血病慢性期老年患者低剂量达沙替尼的长期疗效:DAVLEC II期试验的扩展随访研究

2026-05-280
OA
Comparable outcomes with 14-, 21-, or standard 28-day venetoclax in the first cycle of azacitidine–venetoclax in untreated acute myeloid leukemia: real-world experience from the Hokkaido Leukemia Net

与第一周期阿扎胞苷-维奈克拉组合中14天、21天或标准28天维奈克拉治疗相比,在未经治疗的急性髓系白血病中具有可比的结果:来自北海道白血病网的现实世界经验

2025-07-030
OAAI
Optimal Depth of the Treatment Response Before Allogeneic Hematopoietic Transplantation for Chronic Myeloid Leukemia in Chronic Phase

异基因造血干细胞移植前慢性粒细胞白血病慢性期的最佳治疗反应深度

2025-05-120
PRE
Long-Term Survival After Allogeneic Hematopoietic Stem Cell Transplantation for BCR::ABL1-Negative Atypical Chronic Myeloid Leukemia: A Nationwide Retrospective Study by Adult CML/MPN and MDS Working Groups of the Japanese Society for Transplantation and Cellular Therapy

异基因造血干细胞移植治疗BCR::ABL1阴性非典型慢性粒细胞白血病的长期生存率:日本移植与细胞治疗学会成人CML/MPN和MDS工作组开展的一项全国性回顾性研究

2025-02-110
PRE
Combination of Low White Blood Cell Count and Impaired Renal Function Is a Risk Factor for Higher Concentrations of Venetoclax and Prolonged Neutropenia in AML Patients with Venetoclax Combined Regimen: Real World Experience in the Japanese Cohort

低白细胞计数与肾功能受损的组合是接受维奈克拉联合方案治疗的AML患者维奈克拉浓度升高及中性粒细胞减少症持续时间延长的一项风险因素:日本队列的真实世界经验

BLOOD
IF23.1
2024-11-050
PRE
Dominant-negative type of IKZF1 deletion showed a favorable prognosis in adult B-cell acute lymphoblastic leukemia
2023-08-192
PRE
Sez6l2 autoimmunity in a large cohort study
2023-06-015
PRE
Prognostic Factors for Outcomes of Allogeneic HSCT for Children and Adolescents/Young Adults With CML in the TKI Era
2022-07-017
OAAI
High CRP-albumin ratio predicts poor prognosis in transplant ineligible elderly patients with newly diagnosed acute myeloid leukemia
2022-05-259
OAAI
The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation
2022-04-126
PRE
A novel nutritional index simplified CONUT and the disease risk index independently stratify prognosis of elderly patients with acute myeloid leukemia
2020-11-1012
OAAI